CIK 0001953926 · <br>Emerging growth company
Zenas BioPharma, Inc.
Sign in to watch- Ticker
- ZBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-271-2954
- Business address
- 852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
- Former names
- Zenas BioPharma (Cayman) Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | Fairmount Funds Management LLC Director | Conversion | +301,077 | 1,304,891 | ||
| 2024-09-16 | Fairmount Funds Management LLC Director | Purchase | +300,000 | $17.00 | $5.1M | 1,604,891 |
| 2024-09-16 | Fairmount Funds Management LLC Director | Conversion · Series Seed Convertible Preferred Stock | −357,143 | 0 | ||
| 2024-09-16 | Fairmount Funds Management LLC Director | Conversion · Series A Convertible Preferred Stock | −2,195,871 | 0 | ||
| 2024-09-16 | Fairmount Funds Management LLC Director | Conversion · Series B Convertible Preferred Stock | −6,163,236 | 0 | ||
| 2024-09-16 | Fairmount Funds Management LLC Director | Conversion · Series C Convertible Preferred Stock | −2,614,287 | 0 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion | +164,523 | 164,523 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion | +108,381 | 108,381 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion | +372,017 | 536,540 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion | +48,254 | 156,635 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion · Series Seed Convertible Preferred Stock | −1,428,571 | 0 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion · Series A Convertible Preferred Stock | −941,088 | 0 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion · Series B Convertible Preferred Stock | −3,230,268 | 0 | ||
| 2024-09-16 | MOULDER LEON O JR Chief Executive Officer | Conversion · Series B Convertible Preferred Stock | −418,996 | 0 | ||
| 2024-09-16 | Nunn Jason Raleigh Director | Conversion | +1,505,388 | 1,505,388 | ||
| 2024-09-16 | Nunn Jason Raleigh Director | Purchase | +441,176 | $17.00 | $7.5M | 1,946,564 |
| 2024-09-16 | Nunn Jason Raleigh Director | Conversion | +669,061 | 669,061 | ||
| 2024-09-16 | Nunn Jason Raleigh Director | Purchase | +441,176 | $17.00 | $7.5M | 1,110,237 |
| 2024-09-16 | Nunn Jason Raleigh Director | Conversion · Series C Convertible Preferred Stock | −13,071,439 | 0 | ||
| 2024-09-16 | Nunn Jason Raleigh Director | Conversion · Series C Convertible Preferred Stock | −5,809,528 | 0 |
Page 6 of 8 · 145 trades